BIOMAT Database Logo BIOMAT Database Logo

Novel compounds for the treatment of neurodegenerative diseases: patent highlight. 2012

David P Rotella
Department of Chemistry and Biochemistry, Montclair State University , 1 Normal Avenue, Montclair, New Jersey 07043, United States.

UI MeSH Term Description Entries

Related Publications

David P Rotella
Novel indolethylbenzamides for the treatment of tauopathies: patent highlight.
November 2012, ACS medicinal chemistry letters,
David P Rotella
Compositions and methods for the treatment of mitochondrial diseases: patent highlight.
December 2012, ACS medicinal chemistry letters,
David P Rotella
BACE-Inhibitors: Potential Treatment of Alzheimer Disease, Dementia, and Related Neurodegenerative Diseases. C. Spiro-Heterocyclic Derivatives: Patent Highlight.
November 2012, ACS medicinal chemistry letters,
David P Rotella
GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.
December 2012, ACS medicinal chemistry letters,
David P Rotella
Factor D Inhibitors for the Treatment of AMD: Patent Highlight.
October 2012, ACS medicinal chemistry letters,
David P Rotella
The Drosophila Model: Exploring Novel Therapeutic Compounds against Neurodegenerative Diseases.
December 2019, Antioxidants (Basel, Switzerland),
David P Rotella
Fused heterocyclic compounds as ion channel modulators: patent highlight.
August 2012, ACS medicinal chemistry letters,
David P Rotella
Compounds and Their Use as BACE Inhibitors: Patent Highlight.
November 2012, ACS medicinal chemistry letters,
David P Rotella
Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases.
January 2020, Cellular signalling,
David P Rotella
Novel use of leflunomide and malononitrilamides: patent highlight.
October 2012, ACS medicinal chemistry letters,
Copied contents to your clipboard!